Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of the Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation in Patients With Recurrent/Residual Small Hepatocellular Carcinoma (APROH Study)

NCT01963429 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT01963429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01963429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of the Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation in Patients With Recurrent/Residual Small Hepatocellular Carcinoma (APROH Study)
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2013
Completion date
January 20, 2020
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent small hepatocellular carcinoma, residual small hepatocellular carcinoma